Baudax Bio Reports 2022 Fourth Quarter and Annual Financial Results - MyChesCo
MALVERN, PA — Baudax Bio, Inc. (Nasdaq: BXRX) recently reported financial results for the fourth quarter and year ended December 31, 2022, updated the status of the neuromuscular blocking (NMB) …
MyChesCo
